Ticker Symbol: CGEM
Cullinan Oncology Inc
$20.56 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001789972
Company Profile
Cullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: www.cullinanoncology.com
CEO: N/A
Tags:
- Other Consumer Services
- Consumer Services
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $8.73
Change:
$0.17
(
1.99%)
Days Range: $8.43 - $8.92
Beta: 0.90
52wk. High: $13.99
52wk. Low: $7.78
Ytd. Change -16.88%
50 Day Moving Average: $9.52
200 Day Moving Average: $10.33
Shares Outstanding: 42734644
Valuation
Market Cap: 37.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A